Healthcare Global Enterprises Share Price | Healthcare Global Enterprises Stock Screener
HCG
Hospitals
Share Price NSE
₹666.55
▼
-3.35 (-0.50%)
Share Price BSE
₹666.25
▼
-3.05 (-0.46%)
As of July 24, 2026, the Healthcare Global Enterprises share price (NSE: HCG) is ₹666.55 on NSE and ₹666.25 on BSE, down 0.50% from the previous close, with shares trading between ₹660.65 and ₹675.00, and a 52-week range of ₹521.75–₹776.30.
Analyse Healthcare Global Enterprises stock price data download and track historical price performance.
Use the Healthcare Global Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Healthcare Global Enterprises Market Cap
₹9,872.61 Cr.
HCG P/E Ratio (TTM)
427.81
Healthcare Global Enterprises P/B Ratio
7.34
EPS (TTM)
₹0.97
Dividend Yield
-
Debt to Equity
1.78
HCG 52 Week High
₹776.30
Healthcare Global Enterprises 52 Week Low
₹521.75
Operating Margin
14.00%
Profit Margin
0.60%
HCG Revenue (TTM)
₹664.00
EBITDA
₹105.00
Net Income
₹4.00
Total Assets
₹3,923.00
Total Equity
₹1,332.00
Healthcare Global Enterprises Share Price Chart
Screen Healthcare Global Enterprises share price with an interactive chart. Analyse HCG price trends and volatility across different timeframes.
Healthcare Global Enterprises Company Profile - Fundamental Screener
Screen Healthcare Global Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for HCG shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE075I01017
Healthcare Global Enterprises Balance Sheet Screener
Screen HCG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,923 | 3,543 | 2,708 | 2,316 | 2,220 | 2,036 | 2,253 | 1,654 | 1,444 | 1,226 |
| Current Assets | 1,135 | 844 | 680 | 580 | 502 | 435 | 304 | 273 | 220 | 244 |
| Fixed Assets | 2,093 | 2,442 | 1,758 | 1,553 | 1,547 | 1,382 | 1,646 | 970 | 828 | 685 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,495 | 1,507 | 1,099 | 876 | 866 | 856 | 1,258 | 584 | 506 | 371 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,332 | 990 | 865 | 869 | 884 | 714 | 420 | 522 | 579 | 490 |
| Share Capital | 149 | 139 | 139 | 139 | 139 | 125 | 89 | 88 | 87 | 86 |
| Reserves & Surplus | 1,183 | 783 | 687 | 721 | 731 | 528 | 293 | 389 | 398 | 347 |
Healthcare Global Enterprises Income Statement Screener - Profit & Revenue Analysis
Screen Healthcare Global Enterprises income statement and profit fundamentals.
Analyze HCG quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Healthcare Global Enterprises share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 664 | 594 | 619 | 648 | 634 | 502 | 534 | 564 | 563 | 446 | 463 | 489 | 475 | 367 | 410 |
| Expenses | 559 | 480 | 505 | 524 | 536 | 403 | 435 | 451 | 470 | 365 | 386 | 402 | 391 | 302 | 336 |
| EBITDA | 105 | 114 | 114 | 125 | 98 | 100 | 99 | 112 | 93 | 80 | 76 | 87 | 84 | 65 | 74 |
| Operating Profit % | 14.00% | 18.00% | 17.00% | 19.00% | 15.00% | 18.00% | 17.00% | 18.00% | 16.00% | 17.00% | 16.00% | 17.00% | 17.00% | 17.00% | 18.00% |
| Depreciation | 63 | 58 | 58 | 63 | 61 | 46 | 47 | 50 | 57 | 42 | 41 | 43 | 44 | 41 | 40 |
| Interest | 43 | 44 | 46 | 44 | 45 | 27 | 34 | 36 | 41 | 26 | 26 | 27 | 30 | 24 | 25 |
| Profit Before Tax | 1 | 14 | 12 | 20 | -6 | 28 | 19 | 28 | -3 | 13 | 11 | 18 | 11 | 1 | 10 |
| Tax | -3 | 7 | 6 | -1 | 2 | 5 | 5 | 7 | -11 | 8 | 7 | 7 | 8 | -1 | 8 |
| Net Profit | 4 | 7 | 6 | 21 | -8 | 24 | 14 | 21 | 8 | 6 | 4 | 11 | 3 | 2 | 3 |
| EPS | 0.15 | 0.53 | 0.34 | 1.16 | -0.68 | 1.53 | 0.87 | 1.29 | 0.50 | 0.60 | 0.55 | 0.97 | 0.41 | 0.43 | 0.44 |
Healthcare Global Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen HCG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 317 | 285 | 252 | 220 | 121 | 130 | 99 | 98 | 91 | 73 |
| Investing Activities | -488 | -226 | -133 | 125 | -171 | -101 | -238 | -283 | -210 | -204 |
| Financing Activities | -42 | -64 | -140 | -155 | 112 | -58 | 84 | 161 | 89 | 216 |
| Net Cash Flow | -213 | -5 | -22 | 190 | 62 | -30 | -56 | -24 | -29 | 85 |
Healthcare Global Enterprises Shareholding Pattern Screener
See Healthcare Global Enterprises shareholding pattern with promoter, FII, and DII holdings.
Check Healthcare Global Enterprises promoter holding and ownership changes for HCG on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 64.21% | 64.21% | 71.22% | 62.46% | 63.78% | 63.77% | 71.28% | 71.25% |
| FII Holding | 2.75% | 2.74% | 2.45% | 2.16% | 3.59% | 3.22% | 6.74% | 3.95% |
| DII Holding | 18.91% | 19.20% | 12.47% | 13.22% | 18.36% | 18.30% | 8.52% | 10.89% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.79% | 10.83% | 10.43% | 10.50% | 10.41% | 11.20% | 9.39% | 9.41% |
| Other Holding | 3.34% | 3.02% | 3.43% | 11.66% | 3.86% | 3.51% | 4.07% | 4.49% |
| Shareholder Count | 47,576 | 48,905 | 45,394 | 47,028 | 46,970 | 45,366 | 27,195 | 26,529 |
Healthcare Global Enterprises Share Dividend Screener - Share Yield Analysis
Check Healthcare Global Enterprises dividend history with payout and yield data.
View Healthcare Global Enterprises dividend details including ex-dates and amounts for HCG stock.
Healthcare Global Enterprises Stock Index Membership
See which indices include Healthcare Global Enterprises stock.
Check HCG index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Healthcare Global Enterprises Market Events Screener - Corporate Actions
Get Healthcare Global Enterprises corporate actions including splits, bonuses, and buybacks.
Check Healthcare Global Enterprises stock events that may affect HCG share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-19 | 2026-05-19 | Quarterly Result Announcement | NA | 10.44% |
| 2026-03-02 | 2026-03-02 | Rights | 1:17 | -2.67% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | -3.39% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.96% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | -6.27% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 9.77% |
| 2025-05-24 | 2025-05-24 | Quarterly Result Announcement | NA | 8.06% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.85% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 10.51% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | 5.42% |
Healthcare Global Enterprises Competitors Screener - Peer Comparison
Screen HCG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 128,349 | 63.97 | 25,229 | 14.70% | 2,032 | 64.73 |
| Max Healthcare Institute | 107,096 | 74.35 | 8,536 | 18.82% | 1,442 | 53.46 |
| Fortis Healthcare | 73,155 | 67.51 | 9,179 | 16.93% | 1,064 | 52.56 |
| Aster DM Healthcare | 42,147 | 166.24 | 4,643 | 8.32% | 384 | 58.37 |
| Narayana Hrudayalaya | 40,825 | 51.37 | 7,896 | 41.63% | 788 | 54.04 |
| Global Health | 36,098 | 64.62 | 4,410 | 16.94% | 584 | 60.06 |
| Krishna Institute of Medical Sciences | 33,199 | 136.90 | 3,905 | 27.31% | 198 | 46.69 |
| Dr. Agarwal's Health Care | 15,399 | 91.34 | 2,080 | 18.39% | 168 | 55.83 |
| Rainbow Childrens Medicare | 15,068 | 53.78 | 1,747 | 11.49% | 282 | 62.78 |
| Park Medi World | 11,692 | 44.08 | 1,679 | 17.77% | 272 | 44.04 |
Healthcare Global Enterprises Company Announcements - News Screener
Screen HCG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-09 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-07-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Closure of Trading Window | - |
| 2026-06-29 | Announcement under Regulation 30 (LODR)-Diversification / Disinvestment | - |
| 2026-06-17 | Suspension Of HCG KR Unit Ethics Committee (Bangalore) From Approving Or Overseeing Any New Clinical Trial For A Period Of 24 Months. | - |
| 2026-06-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-08 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-05-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-20 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-20 | Statement Of Deviation Or Variation Of The Proceeds Of Rights Issue For The Quarter Ended March 31 2026. | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-19 | Re-Appointment Of Internal Auditor Of The Company | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Change in Management | - |